NCT07026591

Brief Summary

Epilepsy can lead to cognitive impairments, particularly in attention, which may affect daily activities such as driving. Driving plays a key role in maintaining autonomy and is essential for the social and professional integration of people with epilepsy. Therefore, assessing fitness to drive is a major issue for individuals with epilepsy. French legislation governing driving for people with epilepsy clearly outlines the periods during which a person is not permitted to drive. However, the means or methods for evaluating driving fitness in these individuals are not well defined. Currently, assessment is based more on a medical consultation than on a comprehensive evaluation of driving ability. Using a driving simulator in combination with an EEG could be a valuable approach to better assess the impact of epilepsy-related cognitive impairments on driving performance.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for all trials

Timeline
17mo left

Started Nov 2025

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress31%
Nov 2025Nov 2027

First Submitted

Initial submission to the registry

May 27, 2025

Completed
22 days until next milestone

First Posted

Study publicly available on registry

June 18, 2025

Completed
5 months until next milestone

Study Start

First participant enrolled

November 6, 2025

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2027

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2027

Last Updated

December 17, 2025

Status Verified

December 1, 2025

Enrollment Period

2 years

First QC Date

May 27, 2025

Last Update Submit

December 9, 2025

Conditions

Outcome Measures

Primary Outcomes (8)

  • Speed

    Mean speed during the simulated driving task

    Day 0

  • Phasic alertness

    Phasic alertness on neuropsychological test (TAP)

    Day 0

  • Lane position

    Mean lane position during the simulated driving task

    Day 0

  • Braking time

    Mean braking time during the simulated driving task

    Day 0

  • Information processing time

    Mean information processing time during the simulated driving task

    Day 0

  • Sustained attention

    Sustained attention on neuropsychological test (TAP)

    Day 0

  • Divided attention

    Divided attention on neuropsychological test (TAP)

    Day 0

  • Visual scanning

    Visual scanning on neuropsychological test (TAP)

    Day 0

Study Arms (2)

epilectic patients

Individuals with epilepsy who drive at least once a month

healthy volunteers

healthy volunteers driving at leat once a month, matched to epileptic patients on age (+-/ 5 years), sex and driving experience (+/-3 years)

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Epileptic patients and healthy volunteers

You may qualify if:

  • Aged between 18 and 65 years
  • Holder of a category B driving license
  • Active driver: drives at least once a month
  • No medical condition contraindicating driving, except for epilepsy
  • Provides explicit consent to participate in the study
  • Affiliated with or a beneficiary of a social security scheme

You may not qualify if:

  • Subject to legal protection (guardianship and curatorship are accepted for individuals with epilepsy, as this population represents a significant proportion of our institution's patients)
  • Pregnant or breastfeeding women
  • Known cybersickness (virtual reality or simulator sickness)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Institut La Teppe

Tain-l'Hermitage, 26600, France

RECRUITING

MeSH Terms

Conditions

Epilepsy

Condition Hierarchy (Ancestors)

Brain DiseasesCentral Nervous System DiseasesNervous System Diseases

Central Study Contacts

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
CROSS SECTIONAL
Sponsor Type
NETWORK
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 27, 2025

First Posted

June 18, 2025

Study Start

November 6, 2025

Primary Completion (Estimated)

November 1, 2027

Study Completion (Estimated)

November 1, 2027

Last Updated

December 17, 2025

Record last verified: 2025-12

Locations